155 related articles for article (PubMed ID: 9137424)
1. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
2. Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer.
Murahashi K; Yashiro M; Inoue T; Nishimura S; Matsuoka T; Sawada T; Sowa M; Hirakawa-Ys Chung K
Int J Oncol; 1998 Dec; 13(6):1235-40. PubMed ID: 9824637
[TBL] [Abstract][Full Text] [Related]
3. Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts.
Yashiro M; Murahashi K; Matsuoka T; Nakazawa K; Tanaka H; Osaka H; Koyama T; Ohira M; Chung KH
Anticancer Res; 2003; 23(5A):3899-904. PubMed ID: 14666694
[TBL] [Abstract][Full Text] [Related]
4. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
[TBL] [Abstract][Full Text] [Related]
5. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
7. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
11. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.
Saito H; Fushida S; Harada S; Miyashita T; Oyama K; Yamaguchi T; Tsukada T; Kinoshita J; Tajima H; Ninomiya I; Ohta T
Gastric Cancer; 2018 Jan; 21(1):55-67. PubMed ID: 28540637
[TBL] [Abstract][Full Text] [Related]
12. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction.
Nakajima K; Okita Y; Matsuda S
Oncol Rep; 2004 Jul; 12(1):85-90. PubMed ID: 15201964
[TBL] [Abstract][Full Text] [Related]
14. Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma.
Yashiro M; Chung YS; Sowa M
Jpn J Cancer Res; 1994 Sep; 85(9):883-6. PubMed ID: 7961114
[TBL] [Abstract][Full Text] [Related]
15. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Br J Cancer; 1995 Nov; 72(5):1200-10. PubMed ID: 7577468
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms responsible for the progression of scirrhous gastric cancer].
Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K
Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567
[TBL] [Abstract][Full Text] [Related]
17. Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.
Fujihara T; Sawada T; Hirakawa K; Chung YS; Yashiro M; Inoue T; Sowa M
Clin Exp Metastasis; 1998 May; 16(4):389-98. PubMed ID: 9626818
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a new scirrhous gastric carcinoma cell line with microsatellite instability.
Koyama T; Yashiro M; Matsuoka T; Sunami T; Ohira M; Hirakawa K
Oncol Rep; 2004 Aug; 12(2):317-21. PubMed ID: 15254696
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of a new scirrhous gastric cancer cell line OCUM-2M from a primary gastric tumor].
Yashiro M; Chung YS; Nishimura S; Yamada N; Sawada T; Kubo T; Nakata B; Sowa M
Nihon Shokakibyo Gakkai Zasshi; 1995 Mar; 92(3):199-205. PubMed ID: 7731088
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis and progression of scirrhous carcinoma].
Naito Y; Kino I
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2364-70. PubMed ID: 7944478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]